Riskpilot← Back to searchSign inGet full accessPharmetheus AB
ABActiveOrg 5568956352Kungsängstull 4Engineering activities and related technical consultancy · NACE 7112Est. 201282 employees
Revenue 2024
SEK 190,7M
-1% vs 2023
EBITDA margin
8.5%
-67% vs 2023
Equity ratio
34.7%
Financial strength
Net profit 2024
SEK 11,2M
-70% vs 2023
| Revenue | SEK 190,7M | -1% |
| EBITDA | SEK 16,2M | -67% |
| Net profit | SEK 11,2M | -70% |
| Total assets | SEK 86,1M | -16% |
| Equity | SEK 29,9M | -30% |
| Employees | 82 | — |
Legal name
Pharmetheus AB
Org number
5568956352
Legal form
Aktiebolag
NACE code
7112 · Engineering activities and related technical consultancy
Founded
11 juni 2012
Share capital
SEK 63 000
Employees
82 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-11-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva konsult- och analystjänster inom läkemedels- och bioteknikbranschen, utveckling av modeller och programvara för samma område samt därmed förenlig verksamhet.
Address
Kungsängstull 4
Phone
+4618513328
Email
finance@pharmetheus.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 50 140 | 70 811 | 91 001 | 104 597 | 149 810 | 191 783 | 190 666 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 11 365 | 8 329 | 4 447 | 13 823 | 10 323 | 18 457 | 22 481 | 39 036 | 49 766 | 16 205 |
| Depreciation & amort. | −150 | −180 | −182 | −128 | −384 | −347 | −432 | −452 | −643 | −834 |
| EBIT | 11 215 | 8 149 | 4 265 | 13 695 | 9 939 | 18 110 | 22 049 | 38 584 | 49 123 | 15 371 |
| Net financials | −9 | −78 | −91 | −69 | −72 | −173 | −106 | −88 | 108 | 352 |
| Profit before tax | 11 190 | 8 129 | 2 795 | 12 843 | 9 439 | 13 229 | 15 653 | 27 599 | 47 349 | 14 402 |
| Tax | −2 491 | −1 823 | −698 | −2 909 | −2 145 | −2 906 | −3 389 | −5 762 | −10 008 | −3 184 |
| Net profit | 8 699 | 6 306 | 2 097 | 9 934 | 7 294 | 10 323 | 12 264 | 21 837 | 37 341 | 11 218 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 21 840 | 15 502 | 10 026 | 22 137 | 25 742 | 32 097 | 42 023 | 73 472 | 102 545 | 86 149 |
| Equity | 11 911 | 6 417 | 2 214 | 10 058 | 8 553 | 11 676 | 13 221 | 24 058 | 42 397 | 29 870 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 7 840 | 7 054 | 5 812 | 9 946 | 15 056 | 15 121 | 18 302 | 29 714 | 40 448 | 36 579 |
| Total debt | 7 840 | 7 054 | 5 812 | 9 946 | 15 056 | 15 121 | 18 302 | 29 714 | 40 448 | 36 579 |
EBITDA margin
8.5%
This company
15.8%
Market median
-46% vs market
20152024
Equity ratio
34.7%
This company
38.2%
Market median
+9% vs market
20152024
Return on equity
37.6%
This company
18.4%
Market median
+104% vs market
20152024
Net profit margin
5.9%
This company
8.1%
Market median
-27% vs market
20152024
Asset turnover
2.21×
This company
1.12×
Market median
+97% vs market
20152024
Debt / equity
1.88×
This company
0.62×
Market median
-203% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-12-01 – 2024-11-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-12-01 – 2023-11-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-12-01 – 2022-11-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-12-01 – 2021-11-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-12-01 – 2020-11-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-12-01 – 2019-11-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-12-01 – 2018-11-30
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-12-01 – 2017-11-30
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-12-01 – 2016-11-30
- Annual report 2015Filed via Bolagsverket / SCB · Period 2014-12-01 – 2015-11-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
EL Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
PA Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
JK | Audit | 2020 | — | — |
EM Auditor Substitute | Auditor Substitute | 2020 | — | — |
JE Chief Auditor | Chief Auditor | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
New Pharmetheus Holding AB | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
New Pharmetheus Holding AB
Pharmetheus AB (this company)Pharmetheus Canada Inc.Pharmetheus Canada IncPharmetheus U.S. Inc.Pharmetheus France SasPHARMETHEUS CANADA INC.PHARMETHEUS FRANCE SASPHARMETHEUS U.S. INC.Board members of Pharmetheus AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Elodie Laetitia Plan | Chief Executive Officer | 0 companies |
| Peter Andrew Milligan | Chief Executive Officer | 0 companies |
| Johanna Katarina Boive | Audit | 0 companies |
| Eva Maria Andersson Dverstorp | Auditor Substitute | 0 companies |
| Johan Erik Niclas Bergenmo | Chief Auditor | 0 companies |
| Per Tomas Salomonsson | Board of Directors | 0 companies |
| Jan Per Martin Bergstrand | Board of Directors | 0 companies |
| Karl Joakim Nyberg | Board of Directors | 0 companies |
| Birgitta Marie Sandström | Board of Directors | 0 companies |
| Sofia Helena Friberg Hietala | Board of Directors | 0 companies |
| Bo Sverre Bengtsson | Board of Directors | 0 companies |
| Birgit Köster Hoffmann | Board of Directors | 0 companies |
| Mats Olof Karlsson | Board of Directors | 0 companies |
| Magnus Axel Sigvard Forsbrand | Chairman | 0 companies |
| Agneta Ingegerd Franksson | Board of Directors | 0 companies |
| Fredrik Veimar Alpsten | Board of Directors | 0 companies |